Total Company Value: Bolt Biotherapeutics, Inc. (BOLT)
Bolt Biotherapeutics is attracting leading antibody specialists, creating a science-driven environment with a focus on patents and stock option bonuses. The Enterprise Value price action, which currently stands at 16.09, clearly demonstrates the market valuation of the business. The company focuses on developing tumor-fighting methods, planning for long-term revenue from intellectual property rights in partnership with global pharma behemoths.
Bolt Biotherapeutics, Inc. (BOLT) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Bolt Biotherapeutics (BOLT)
Enterprise Value combines market capitalization with net debt to determine the theoretical cost of a full business buyout. This metric is sensitive to changes in liquidity and the debt load reported in financial statements. By analyzing the company's market price while accounting for cash and debt, an investor gains a view of the actual scale of assets. For Bolt Biotherapeutics (BOLT), this indicator reflects the value of its antibody platform and the potential for future royalties.
Competitor analysis for Bolt Biotherapeutics
argenx N.V. - Total Enterprise Value|BNTX - Total Company Value|Abivax Pharma (ABVX) - Total Company Value|ADMA - Real Price to Acquire Entire Company|PTGX (protagonist-inc.com) - Aggregate Business Value|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Enterprise Value|Value Adjusted for Debt and Cash Adaptive Biotechnologies Inc. (ADPT)|Enterprise Value CLDX (Celldex Therapeutics)|auriniapharma.com - Enterprise Value|Total Company Value BioCryst Pharmaceuticals (BCRX)|VERA: Value Adjusted for Debt and Cash|DNTH (Dianthus Pharma) - Total Company Value|Pharvaris Pharma (PHVS) - Real Price to Acquire Entire Company|ABCL (AbCellera Biologics Inc) - Enterprise Value|Enterprise Value tourmalinebio.com (TRML)|Precigen (PGEN) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Pharming Group NV (PHAR)|Enterprise Value NKTR|Upstream Pharma - Company Buyout Price|ZBIO: Total Company Value|IMNM: Real Price to Acquire Entire Company|GOSS (Gossamer Bio) - Total Company Value|Real Price to Acquire Entire Company KalVista Pharma|SEPN (Septerna Corp) - Real Price to Acquire Entire Company|Enterprise Value PVLA|Total Company Value Savara Inc. SVRA|Business Value rigel.com (RIGL)|ANAB: Enterprise Value|Total Enterprise Value Astria Therapeutics Inc ATXS|ENGN - Enterprise Value|RAPT: Total Company Value|Total Company Value JBIO|ACRS (aclaristx.com) - Total Enterprise Value|Total Company Value Kyverna Therapeutics, Inc.|Total Company Value Tiziana Life Sciences Ltd. (TLSA)|Real Price to Acquire Entire Company Cabaletta Bio, Inc|Aggregate Business Value Ventyx Biosciences, Inc VTYX|Real Price to Acquire Entire Company Theratechnologies Inc.|Value Adjusted for Debt and Cash avalotx.com AVTX|ELDN - Enterprise Value|AGEN - Total Company Value|Climb Bio, Inc. - Enterprise Value|ZURA (Zura Bio Ltd) - Company Buyout Price|Total Company Value ATYR (aTyr Pharma, Inc.)|Total Enterprise Value Adagene Corp (ADAG)|Real Price to Acquire Entire Company ImageneBio Inc|Aggregate Business Value shattucklabs.com (STTK)|Enterprise Value Equillium|Value Adjusted for Debt and Cash Connect Biopharma Holdings CNTB|IMUX (Immunic Inc) - Enterprise Value|ATRA: Total Enterprise Value|Total Company Value inflarx.de IFRX|X4 Pharmaceuticals Inc. (XFOR) - Value Adjusted for Debt and Cash|ACET (Adicet Bio Inc.) - Enterprise Value|Enterprise Value CELU|INMB - Total Company Value|Full Business Value barinthusbio.com (BRNS)|KZR: Enterprise Value|SABS - Total Enterprise Value|Akari Therapeutics plc - Real Price to Acquire Entire Company|Enlivex Therapeutics (ENLV) - Enterprise Value|QTTB - Real Price to Acquire Entire Company|geovax.com (GOVX) - Aggregate Business Value|EDSA: Enterprise Value|Company Buyout Price iBio Inc|Enterprise Value CARM (Carisma Therapeutics)|Real Price to Acquire Entire Company XTLB (XTL Bio)|Total Company Value HCWB|Company Buyout Price Aptevo Therapeutics, Inc. APVO|AIM - Enterprise Value|ADTX: Total Company Value|Total Company Value GRI|XRTX (XORTX Corp) - Total Enterprise Value|Total Company Value Vyome Holdings Inc|Total Company Value revbiosciences.com (REVB)|Real Price to Acquire Entire Company Indaptus Therapeutics, Inc.|Aggregate Business Value SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica (CALI) - Total Company Value|Full Business Value Affimed NV AFMD|Enterprise Value Allakos Therapeutics (ALLK)|HOOK - Value Adjusted for Debt and Cash|IGMS: Enterprise Value|ITOS (iTeos Therapeutics Inc) - Enterprise Value|OCEA - Total Company Value|Value Adjusted for Debt and Cash TCBP|Total Company Value THRD (Third Harmonic Bio)